FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- 30 June 1996
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 58 (3) , 299-305
- https://doi.org/10.1016/0960-0760(96)00040-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 5α‐Reductase inhibitors and prostatic diseaseClinical Endocrinology, 1994
- 6-Azasteroids: Structure-Activity Relationships for Inhibition of Type 1 and 2 Human 5.alpha.-Reductase and Human Adrenal 3.beta.-Hydroxy-.DELTA.5-steroid Dehydrogenase/3-Keto-.DELTA.5-steroid IsomeraseJournal of Medicinal Chemistry, 1994
- Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5α-reductase isoform 2The Journal of Steroid Biochemistry and Molecular Biology, 1994
- Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.Journal of Clinical Investigation, 1993
- FinasterideDrugs, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.Journal of Clinical Investigation, 1992
- Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditismNature, 1991
- Potent inhibition of human steroid 5α-reductase (EC 1.3.1.30) by 3-androstene-3-carboxylic acidsBioorganic Chemistry, 1989
- 5α-Reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the ratSteroids, 1986